vs
科睿唯安（CLVT）与EDGEWELL PERSONAL CARE Co（EPC）财务数据对比。点击上方公司名可切换其他公司
科睿唯安的季度营收约是EDGEWELL PERSONAL CARE Co的1.4倍（$585.5M vs $422.8M），科睿唯安净利率更高（-6.9% vs -15.5%，领先8.7%），科睿唯安同比增速更快（-1.4% vs -11.6%），科睿唯安自由现金流更多（$78.9M vs $-137.5M），过去两年科睿唯安的营收复合增速更高（-5.1% vs -16.0%）
科睿唯安是一家英美合资的上市分析服务企业，主要提供订阅制信息服务，覆盖文献计量、科学计量、商业与市场情报领域，同时为医药、生物科技行业提供专利、监管合规相关的竞争分析，也提供商标保护、域名与品牌保护服务，旗下Web of Science产品系列还负责计算学术期刊的影响因子。
Edgewell个人护理是一家总部位于美国康涅狄格州谢尔顿的跨国消费品企业，主营业务聚焦个人护理产品领域。公司在2015年从劲量控股分拆后正式成立，目前在全球多个市场开展个人护理相关业务。
CLVT vs EPC — 直观对比
营收规模更大
CLVT
是对方的1.4倍
$422.8M
营收增速更快
CLVT
高出10.2%
-11.6%
净利率更高
CLVT
高出8.7%
-15.5%
自由现金流更多
CLVT
多$216.4M
$-137.5M
两年增速更快
CLVT
近两年复合增速
-16.0%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $585.5M | $422.8M |
| 净利润 | $-40.2M | $-65.7M |
| 毛利率 | 67.2% | 38.1% |
| 营业利润率 | 5.2% | -4.5% |
| 净利率 | -6.9% | -15.5% |
| 营收同比 | -1.4% | -11.6% |
| 净利润同比 | 61.3% | -3028.6% |
| 每股收益（稀释后） | $-0.06 | $-1.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLVTEPC
| Q1 26 | $585.5M | — | ||
| Q4 25 | $617.0M | $422.8M | ||
| Q3 25 | $623.1M | $600.5M | ||
| Q2 25 | $621.4M | $627.2M | ||
| Q1 25 | $593.7M | $580.7M | ||
| Q4 24 | $663.0M | $415.1M | ||
| Q3 24 | $622.2M | $517.6M | ||
| Q2 24 | $650.3M | $647.8M |
净利润CLVTEPC
| Q1 26 | $-40.2M | — | ||
| Q4 25 | $3.1M | $-65.7M | ||
| Q3 25 | $-28.3M | $-30.6M | ||
| Q2 25 | $-72.0M | $29.1M | ||
| Q1 25 | $-103.9M | $29.0M | ||
| Q4 24 | $-191.8M | $-2.1M | ||
| Q3 24 | $-65.6M | $8.8M | ||
| Q2 24 | $-304.3M | $49.0M |
毛利率CLVTEPC
| Q1 26 | 67.2% | — | ||
| Q4 25 | 66.8% | 38.1% | ||
| Q3 25 | 65.0% | 37.9% | ||
| Q2 25 | 67.2% | 42.8% | ||
| Q1 25 | 65.1% | 44.1% | ||
| Q4 24 | 65.7% | 41.6% | ||
| Q3 24 | 66.2% | 41.1% | ||
| Q2 24 | 67.2% | 44.3% |
营业利润率CLVTEPC
| Q1 26 | 5.2% | — | ||
| Q4 25 | 6.7% | -4.5% | ||
| Q3 25 | 7.1% | -4.2% | ||
| Q2 25 | 1.1% | 8.6% | ||
| Q1 25 | -3.5% | 10.1% | ||
| Q4 24 | -9.4% | 2.2% | ||
| Q3 24 | 3.5% | 3.9% | ||
| Q2 24 | -36.9% | 12.8% |
净利率CLVTEPC
| Q1 26 | -6.9% | — | ||
| Q4 25 | 0.5% | -15.5% | ||
| Q3 25 | -4.5% | -5.1% | ||
| Q2 25 | -11.6% | 4.6% | ||
| Q1 25 | -17.5% | 5.0% | ||
| Q4 24 | -28.9% | -0.5% | ||
| Q3 24 | -10.5% | 1.7% | ||
| Q2 24 | -46.8% | 7.6% |
每股收益（稀释后）CLVTEPC
| Q1 26 | $-0.06 | — | ||
| Q4 25 | $0.00 | $-1.41 | ||
| Q3 25 | $-0.04 | $-0.65 | ||
| Q2 25 | $-0.11 | $0.62 | ||
| Q1 25 | $-0.15 | $0.60 | ||
| Q4 24 | $-0.27 | $-0.04 | ||
| Q3 24 | $-0.09 | $0.18 | ||
| Q2 24 | $-0.46 | $0.98 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | — |
| 总债务越低越好 | $4.3B | $1.5B |
| 股东权益账面价值 | $4.8B | $1.5B |
| 总资产 | $10.9B | $3.8B |
| 负债/权益比越低杠杆越低 | 0.89× | 1.03× |
8季度趋势，按日历期对齐
现金及短期投资CLVTEPC
| Q1 26 | — | — | ||
| Q4 25 | $329.2M | — | ||
| Q3 25 | $318.7M | — | ||
| Q2 25 | $362.6M | — | ||
| Q1 25 | $354.0M | — | ||
| Q4 24 | $295.2M | — | ||
| Q3 24 | $388.5M | $209.1M | ||
| Q2 24 | $376.4M | — |
总债务CLVTEPC
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.3B | $1.5B | ||
| Q3 25 | $4.4B | $1.4B | ||
| Q2 25 | $4.5B | $1.4B | ||
| Q1 25 | $4.5B | $1.4B | ||
| Q4 24 | $4.5B | $1.4B | ||
| Q3 24 | $4.6B | $1.3B | ||
| Q2 24 | $4.6B | $1.3B |
股东权益CLVTEPC
| Q1 26 | $4.8B | — | ||
| Q4 25 | $4.8B | $1.5B | ||
| Q3 25 | $4.9B | $1.6B | ||
| Q2 25 | $5.0B | $1.6B | ||
| Q1 25 | $5.0B | $1.5B | ||
| Q4 24 | $5.1B | $1.5B | ||
| Q3 24 | $5.5B | $1.6B | ||
| Q2 24 | $5.6B | $1.6B |
总资产CLVTEPC
| Q1 26 | $10.9B | — | ||
| Q4 25 | $11.1B | $3.8B | ||
| Q3 25 | $11.2B | $3.8B | ||
| Q2 25 | $11.4B | $3.8B | ||
| Q1 25 | $11.5B | $3.8B | ||
| Q4 24 | $11.5B | $3.7B | ||
| Q3 24 | $12.0B | $3.7B | ||
| Q2 24 | $12.1B | $3.7B |
负债/权益比CLVTEPC
| Q1 26 | 0.89× | — | ||
| Q4 25 | 0.89× | 1.03× | ||
| Q3 25 | 0.90× | 0.89× | ||
| Q2 25 | 0.90× | 0.88× | ||
| Q1 25 | 0.90× | 0.95× | ||
| Q4 24 | 0.88× | 0.97× | ||
| Q3 24 | 0.84× | 0.81× | ||
| Q2 24 | 0.83× | 0.82× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $134.7M | $-125.9M |
| 自由现金流经营现金流 - 资本支出 | $78.9M | $-137.5M |
| 自由现金流率自由现金流/营收 | 13.5% | -32.5% |
| 资本支出强度资本支出/营收 | 9.5% | 2.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $333.9M | $36.3M |
8季度趋势，按日历期对齐
经营现金流CLVTEPC
| Q1 26 | $134.7M | — | ||
| Q4 25 | $159.9M | $-125.9M | ||
| Q3 25 | $181.1M | $74.1M | ||
| Q2 25 | $116.3M | $114.8M | ||
| Q1 25 | $171.2M | $45.1M | ||
| Q4 24 | $141.3M | $-115.6M | ||
| Q3 24 | $202.9M | $-388.3M | ||
| Q2 24 | $126.2M | $101.2M |
自由现金流CLVTEPC
| Q1 26 | $78.9M | — | ||
| Q4 25 | $89.2M | $-137.5M | ||
| Q3 25 | $115.5M | $46.5M | ||
| Q2 25 | $50.3M | $99.3M | ||
| Q1 25 | $110.3M | $28.0M | ||
| Q4 24 | $59.1M | $-132.4M | ||
| Q3 24 | $126.3M | $-414.2M | ||
| Q2 24 | $60.3M | $88.6M |
自由现金流率CLVTEPC
| Q1 26 | 13.5% | — | ||
| Q4 25 | 14.5% | -32.5% | ||
| Q3 25 | 18.5% | 7.7% | ||
| Q2 25 | 8.1% | 15.8% | ||
| Q1 25 | 18.6% | 4.8% | ||
| Q4 24 | 8.9% | -31.9% | ||
| Q3 24 | 20.3% | -80.0% | ||
| Q2 24 | 9.3% | 13.7% |
资本支出强度CLVTEPC
| Q1 26 | 9.5% | — | ||
| Q4 25 | 11.5% | 2.7% | ||
| Q3 25 | 10.5% | 4.6% | ||
| Q2 25 | 10.6% | 2.5% | ||
| Q1 25 | 10.3% | 2.9% | ||
| Q4 24 | 12.4% | 4.0% | ||
| Q3 24 | 12.3% | 5.0% | ||
| Q2 24 | 10.1% | 1.9% |
现金转化率CLVTEPC
| Q1 26 | — | — | ||
| Q4 25 | 51.58× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.95× | ||
| Q1 25 | — | 1.56× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -44.13× | ||
| Q2 24 | — | 2.07× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLVT
| Subscription | $397.5M | 68% |
| Re-occurring | $108.6M | 19% |
| Transactional | $79.4M | 14% |
EPC
| Other | $242.0M | 57% |
| Sunand Skin Care Segment | $131.5M | 31% |
| Shavinggelsandcreams | $32.3M | 8% |
| Wipes And Other Skin Care Products | $17.0M | 4% |
